| SVYAX | VMVAX | SVYAX / VMVAX | |
| Total Expense Ratio | 0.20 | 0.07 | 286% |
| Annual Report Gross Expense Ratio | 0.62 | 0.07 | 886% |
| Fund Existence | 17 years | 14 years | - |
| Gain YTD | 9.945 | 8.872 | 112% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 100000 | 3000 | 3,333% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 277M | 31.8B | 1% |
| Annual Yield % from dividends | 2.49 | 2.20 | 113% |
| Returns for 1 year | -4.12 | 2.82 | -146% |
| Returns for 3 years | 0.56 | 26.82 | 2% |
| Returns for 5 years | 1.88 | 56.57 | 3% |
| Returns for 10 years | 8.26 | 108.57 | 8% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| CDVZX | 18.97 | 0.10 | +0.53% |
| Columbia Intrinsic Value Institutional | |||
| OEQIX | 10.39 | 0.05 | +0.48% |
| Oaktree Emerging Markets Equity I | |||
| MVTRX | 11.51 | 0.01 | +0.09% |
| Transamerica Mid Cap Value Opps R6 | |||
| MIGLX | 18.47 | N/A | N/A |
| Morgan Stanley Inst Global Insgt L | |||
| LGRRX | 30.19 | -0.16 | -0.53% |
| Loomis Sayles Growth A | |||